Trial Identifier: | D9690C00006 |
Sponsor: | AstraZeneca |
Start Date: | December 2024 |
Primary Completion Date: | January 2026 |
Study Completion Date: | February 2027 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
BE | Leuven, BE, 3000 |
GB | Birmingham, GB, B15 2GW |
GB | Cambridge, GB, CB2 0XY |
GB | London, GB, WC1E 6AG |
GB | London, GB, NW10 7NS |
IT | Padova, IT, 35121 |
IT | Roma, IT, 00168 |
IT | Rozzano, IT, 20089 |
NL | Amsterdam, NL, 1081 HV |
NL | Nijmegen, NL, 6525 GA |
PL | Łódź, PL, 91-495 |
PL | Poznan, PL, 60-529 |
PL | Poznań, PL, 60-324 |
PL | Warszawa, PL, 04-501 |
PL | Wrocław, PL, 52-210 |
SE | Linköping, SE, 581 85 |
SE | Stockholm, SE, 17176 |